94762-2
SARS-CoV-2 (COVID-19) Ab [Presence] in Serum or Plasma by Immunoassay
Active
Term Description
Qualitative detection of SARS-CoV-2 antibodies by an immunoassay method, such as an enzyme-linked immunosorbent assay or electrochemiluminescence immunoassay, in serum or plasma. This assay detects but does not differentiate between the antibody subtypes.
Source: Regenstrief LOINC
Part Description
LP417540-4 SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.
The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus.
Source: LOINC
Reference Information
Type | Source | Reference |
---|---|---|
Webcontent | Lab Tests Online®Copyright Copyright © 2021 Lab Tests Online. All rights reserved. | Coronavirus (COVID-19) Testing |
Fully-Specified Name
- Component
- SARS coronavirus 2 Ab
- Property
- PrThr
- Time
- Pt
- System
- Ser/Plas
- Scale
- Ord
- Method
- IA
Additional Names
- Short Name
- SARS-CoV-2 Ab SerPl Ql IA
- Display Name
- SARS-CoV-2 (COVID-19) Ab IA Ql
- Consumer Name Alpha Get Info
- SARS-CoV-2 (COVID-19) antibody, Blood
Ask at Order Entry
81959-9 Public health laboratory ask at order entry panel
This panel contains a convenience grouping of terms for questions commonly asked when an order is placed in a public health laboratory.
LOINC | Name | R/O/C | Cardinality | Example UCUM Units |
---|---|---|---|---|
81959-9 | Public health laboratory ask at order entry panel | |||
Indent81744-5 | Submitter's laboratory test method [Type] in Specimen | |||
Indent81658-7 | Suspected organism [Identifier] in Specimen | |||
Indent86952-9 | Preliminary testing done Specimen | |||
Indent86953-7 | Preliminary testing result Specimen | |||
Indent86955-2 | Preliminary testing affected submission for further testing Specimen | |||
Indent95417-2 | Whether this is the patient's first test for condition of interest | |||
Indent95418-0 | Whether patient is employed in a healthcare setting | |||
Indent95419-8 | Whether the patient has symptoms related to condition of interest | |||
Indent11368-8 | Illness or injury onset date and time | C | ||
Indent77974-4 | Whether the patient was hospitalized for condition of interest | |||
Indent95420-6 | Whether the patient was admitted to intensive care unit (ICU) for condition of interest | |||
Indent95421-4 | Whether patient resides in a congregate care setting | |||
Indent82810-3 | Pregnancy status | C | ||
Indent30525-0 | Age | a |
Example Answer List: LL4994-1
Source: Association of Public Health LaboratoriesAnswer | Code | Score | Answer ID |
---|---|---|---|
NonreactiveCopyright http://snomed.info/sct ID:131194007 Non-reactive (qualifier value) | LA15256-3 | ||
ReactiveCopyright http://snomed.info/sct ID:11214006 Reactive (qualifier value) | LA15255-5 |
Basic Attributes
- Class
- MICRO
- Type
- Laboratory
- First Released
- Version 2.68
- Last Updated
- Version 2.69
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
94504-8 | SARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay |
Member of these Groups Get Info
LOINC Group | Group Name |
---|---|
LG51018-6 | SARSCoV2 antibody detection |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
de-AT | German (Austria) | Synonyms: SARS-CoV-2-AK ql. |
de-DE | German (Germany) | SARS-Coronavirus 2 Ak: |
es-ES | Spanish (Spain) | Panel del SARS-CoV-2 (COVID-19) Anticuerpos: |
es-MX | Spanish (Mexico) | Coronavirus 2 Ab del SARS: |
fr-FR | French (France) | Coronavirus SARS-CoV-2 Ac: |
fr-CA | French (Canada) | coronavirus 2 du SRAS, Ac: |
it-IT | Italian (Italy) | SARS coronavirus 2 Ab: Synonyms: anticorpo Coronavirus della SARS Immunoassay Microbiologia Plasma Presenza o Soglia Punto nel tempo (episodio) SARS-CoV-2 (COVID-19) Siero Siero o Plasma |
nl-NL | Dutch (Netherlands) | SARS-CoV-2 As: Synonyms: antistof; |
pl-PL | Polish (Poland) | SARS-CoV-2 Ab: Synonyms: Koronawirus Przeciwciała do wirusa SARS-CoV-2 (COVID-19) |
zh-CN | Chinese (China) | SARS 冠状病毒 2 抗体: Synonyms: 2019 新型冠状病毒; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=94762-2
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright